SANDIMMUN

Serial Number 73309966
Registration 1237977
710

Registration Progress

Application Filed
May 11, 1981
Under Examination
Approved for Publication
Oct 12, 1982
Published for Opposition
Nov 23, 1982
Registered
May 17, 1983

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: SANDIMMUN
Previous Owner: SANDOZ PHARMACEUTICALS CORPORATION

Trademark Image

SANDIMMUN

Basic Information

Serial Number
73309966
Registration Number
1237977
Filing Date
May 11, 1981
Registration Date
May 17, 1983
Published for Opposition
November 23, 1982
Cancellation Date
February 21, 2004
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
710
Status Date
Feb 21, 2004

Rights Holder

SANDOZ PHARMACEUTICALS CORPORATION

03
Address
59 ROUTE 10
EAST HANOVER, NJ 07936

Ownership History

Sandoz, Inc.

Original Applicant
03
East Hanover, NJ

Sandoz, Inc.

Owner at Publication
03
East Hanover, NJ

Sandoz, Inc.

Original Registrant
03
East Hanover, NJ

SANDOZ PHARMACEUTICALS CORPORATION

New Owner After Registration #10
03
EAST HANOVER, NJ

Legal Representation

Attorney
BARRY A. SOLOMON

USPTO Deadlines

Next Deadline
2694 days remaining
Section 8 & 9 Renewal Due (Principal Register) (50-Year) (Based on R.PRA event 1983-05-17)
Due Date
May 17, 2033
Grace Period Ends
November 17, 2033

Application History

10 events
Date Code Type Description Documents
Feb 21, 2004 CAEX O CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 Loading...
Aug 25, 1989 8.OK O REGISTERED - SEC. 8 (6-YR) ACCEPTED Loading...
May 15, 1989 8.AF I REGISTERED - SEC. 8 (6-YR) FILED Loading...
May 17, 1983 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 23, 1982 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 17, 1983 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 12, 1982 NPUB O NOTICE OF PUBLICATION Loading...
Sep 27, 1982 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 16, 1982 CNRT F NON-FINAL ACTION MAILED Loading...
Mar 31, 1982 DOCK D ASSIGNED TO EXAMINER Loading...

Additional Information

Pseudo Mark
SANDIMMUNE